1. Targeting protein kinases to reverse multidrug resistance in sarcoma
   Hua Chen et al, 2016, Cancer Treatment Reviews CrossRef
2. Ras-mediated activation of mTORC2 promotes breast epithelial cell migration and invasion
   Shannon E. Collins et al, 2023, Molecular Biology of the Cell CrossRef
3. PP242 suppresses bladder cancer cell proliferation and migration through deactivating the mammalian target of rapamycin complex 2/AKT1 signaling pathway
   ZHE ZHANG et al, 2016, Molecular Medicine Reports CrossRef
4. mTOR: An attractive therapeutic target for osteosarcoma?
   Liu Ding et al, 2016, Oncotarget CrossRef
5. Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs
   Amy K. LeBlanc et al, 2021, Clinical Cancer Research CrossRef
6. mTOR signaling in osteosarcoma: Oncogenesis and therapeutic aspects (Review)
   Kai Hu et al, 2016, Oncology Reports CrossRef
7. A panel of eight mRNA signatures improves prognosis prediction of osteosarcoma patients
   Bo Wu et al, 2021, Medicine CrossRef
8. LHX2 promotes malignancy and inhibits autophagy via mTOR in osteosarcoma and is negatively regulated by miR-129-5p
   Honghai Song et al, 2019, Aging CrossRef
9. Ascofuranone suppresses invasion and F-actin cytoskeleton organization in cancer cells by inhibiting the mTOR complex 1 signaling pathway
   Yun-Jeong Jeong et al, 2020, Cellular Oncology CrossRef
10. In Situ Analysis of mTORC1/C2 and Metabolism-Related Proteins in Pediatric Osteosarcoma
    Anna Mohás et al, 2022, Pathology and Oncology Research CrossRef
11. PI3K/Akt signaling in osteosarcoma
    Jian Zhang et al, 2015, Clinica Chimica Acta CrossRef
12. UBXN2A suppresses the Rictor-mTORC2 signaling pathway, an established tumorigenic pathway in human colorectal cancer
    Sanam Sane et al, 2023, Oncogene CrossRef
13. A viral kinase mimics S6 kinase to enhance cell proliferation
    Aadra Prashant Bhatt et al, 2016, Proceedings of the National Academy of Sciences CrossRef
14. Targeted Deletion of Rictor in BMSCs Reduces the Biological Activity of K7M2 Cells and Mitigates OS-Induced Bone Destruction
    Jinhong Lu et al, 2023, Stem Cells CrossRef
15. The translational repressor 4E-BP1 regulates RRM2 levels and functions as a tumor suppressor in Ewing sarcoma tumors
    Kelli L. Goss et al, 2021, Oncogene CrossRef
16. Staufen Impairs Autophagy in Neurodegeneration
    Sharan Paul et al, 2023, Annals of Neurology CrossRef
17. Antimetastatic Therapy
    Nicole S. Amato, 2023, Therapeutic Strategies in Veterinary Oncology CrossRef
18. Evaluation of drug-targetable genes by defining modes of abnormality in gene expression
    Junseong Park et al, 2015, Scientific Reports CrossRef
19. The roles of glycolysis in osteosarcoma
    Zuxi Feng et al, 2022, Frontiers in Pharmacology CrossRef
20. Insight into the interplay between mitochondria-regulated cell death and energetic metabolism in osteosarcoma
    Hong Toan Lai et al, 2022, Frontiers in Cell and Developmental Biology CrossRef